Immunization News and Research

RSS

COVID-19, influenza and suicide are responsible for deaths of ICE detainees

Thirty-five people have died in the custody of U.S. Immigration and Customs Enforcement (ICE) since April 2018, with a seven-fold increase in deaths even as the average daily population decreased by nearly a third between 2019 and 2020, a new USC study shows.

21 Jan 2021

Biden’s covid challenge: 100 million vaccinations in the first 100 days. It won’t be easy.

It's in the nature of presidential candidates and new presidents to promise big things. Just months after his 1961 inauguration, President John F. Kennedy vowed to send a man to the moon by the end of the decade.

20 Jan 2021

Supply chain delays affect planned stockpile of Ebola vaccines

Supply chain delays must be addressed to speed up creation of a stockpile of vaccines against deadly Ebola disease, researchers say.

19 Jan 2021

World Health Assembly calls for urgent action on prevention and control of meningitis

At the 73rd Session of the World Health Assembly, Member States overwhelmingly endorsed a resolution calling for urgent action on meningitis prevention and control through the implementation of a bold, comprehensive global roadmap to defeat meningitis by 2030.

18 Jan 2021

International health organizations establish global Ebola vaccine stockpile

The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response.

18 Jan 2021

Closed SARS-CoV-2 spikes could be a valuable component of future vaccines

Now, researchers at the Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom, reveal that engineered closed S constructs may be valuable immunogens that can induce neutralizing antibodies against a different pattern of epitopes. This allows for the flexibility of vaccines at both the individual and population levels.

18 Jan 2021

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.

17 Jan 2021

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Researchers in the Netherlands, the United States, and Belgium have presented early-stage clinical trial results demonstrating the safety and efficacy of Johnson & Johnson's vaccine candidate for coronavirus disease 2019 (COVID-19).

17 Jan 2021

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Dr. Monte Junker, an Oregon dentist, is waiting for his turn to get vaccinated for Covid even though he considers himself a front-line health worker.

15 Jan 2021

Study compares acceptance of HPV vaccine and meningococcal vaccine

New research from Boston Medical Center finds that using clear, unambiguous language when recommending HPV vaccination both increases vaccine acceptance and increases conversation efficiency while preserving patient satisfaction.

13 Jan 2021

New technology could protect against different coronavirus variants

The SARS-CoV-2 virus that is causing the COVID-19 pandemic is just one of many different viruses in the coronavirus family.

13 Jan 2021

Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant?

Researchers from Pfizer and the University of Texas, USA, have presented evidence showing that people in a previously reported trial of the mRNA-based COVID-19 vaccine, BNT162b2 – commonly known as the Pfizer-BioNTech COVID-19 vaccine – had equivalent neutralizing titers to the N501 and Y501 viruses.

12 Jan 2021

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

An international team of researchers has provided further evidence to confirm the immunogenicity and efficacy of a recombinant adenovirus vaccine currently being tested in phase 3 trials for its ability to protect against infection with severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

11 Jan 2021

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

As the rollout of covid-19 vaccines picks up across the U.S., moving from hospital distribution to pharmacies, pop-up sites and drive-thru clinics, health experts say it's vital that these expanded venues be prepared to handle rare but potentially life-threatening allergic reactions.

11 Jan 2021

Single-dose nanoparticle COVID-19 vaccine elicits virus-neutralizing antibody response in mice

Across the world, health care workers and high-risk groups are beginning to receive COVID-19 vaccines, offering hope for a return to normalcy amidst the pandemic.

8 Jan 2021

As the vulnerable wait, some political leaders’ spouses get covid vaccines

With supplies of covid-19 vaccines scarce, a federal advisory panel recommends first putting shots into the arms of health care workers, who keep the nation's medical system running, and long-term care residents most likely to die from the coronavirus.

8 Jan 2021

Immunization News and Research

COVID-19, influenza and suicide are responsible for deaths of ICE detainees

Biden’s covid challenge: 100 million vaccinations in the first 100 days. It won’t be easy.

Supply chain delays affect planned stockpile of Ebola vaccines

World Health Assembly calls for urgent action on prevention and control of meningitis

International health organizations establish global Ebola vaccine stockpile

Closed SARS-CoV-2 spikes could be a valuable component of future vaccines

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Study compares acceptance of HPV vaccine and meningococcal vaccine

New technology could protect against different coronavirus variants

Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant?

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

Single-dose nanoparticle COVID-19 vaccine elicits virus-neutralizing antibody response in mice

As the vulnerable wait, some political leaders’ spouses get covid vaccines

Is one-dose COVID-19 vaccination better than two?

Low acceptance of COVID-19 vaccine among healthcare workers in USA

Researchers receive £230,000 to develop world's first smart vaccine device

Evidence review: COVID-19 infections are generally 'mild' in children under five years

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News